Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mission BioCapital is a venture capital firm that specializes in early-stage life science and biotechnology investments. The firm is uniquely positioned through its partnership with MBC BioLabs, a network of life science incubators that provide startups with fully equipped laboratory space and operational support. Mission BioCapital manages several funds, including the Mission Pure Alpha Master Fund, which focuses on seed and Series A investments in companies developing innovative therapeutics and platform technologies. Their investment portfolio spans a wide range of therapeutic areas, including oncology, rare diseases, and immunology. By providing both capital and infrastructure, the firm aims to accelerate the transition of promising academic research into successful commercial enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mission Pure Alpha Master.